Furosemide Tablets Solicitation

SOL #: SPE2D2-26-R-0005Pre-Solicitation

Overview

Buyer

DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 12, 2026
2
Last Updated
Apr 21, 2026
3
Response Deadline
May 21, 2026, 7:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Logistics Agency (DLA) Troop Support has issued a Solicitation for Furosemide Tablets to establish a national supply source for the Defense Logistics Agency (DLA), Department of Veterans Affairs (VA), Bureau of Prisons (BoP), and Indian Health Service (IHS) Pharmaceutical Prime Vendor (PPV) programs. This effort aims to ensure consistent product availability, quality, and volume-based pricing for essential pharmaceutical products. Offers are due May 21, 2026, at 3:00 PM EST.

Scope of Work

This solicitation seeks offers for various strengths and counts of Furosemide Tablets, including 20 MG (90 & 1000 count), 40 MG (90 & 1000 count), and 80 MG (500 count). Key requirements include:

  • Products must be FDA approved and meet Therapeutic Equivalence (TE) Code "A" standards.
  • Offerors must provide the National Drug Code (NDC) for each product.
  • Products must be compatible with automated dispensing units and feature child-proof closures for unit-of-use packaging.
  • Bar code labeling conforming to GS1-128 or HIBCC standards, including lot number and expiration date, is mandatory.
  • Compliance with the Drug Supply Chain Security Act (DCSA) and acceptable cGMP status for manufacturing facilities are required.

Contract Details

  • Type: Firm-fixed-price requirements contract.
  • Period of Performance: One base year with four option years, not to exceed five years.
  • Set-Aside: UNRESTRICTED.
  • NAICS Code: 325412 (Size Standard: 1,300 employees).
  • Large businesses must submit a subcontracting plan.
  • Contract price effective within 60 calendar days of award; performance ready within 45 calendar days of award.

Submission & Evaluation

Offers must be submitted electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS).

  • Submission Deadline: May 21, 2026, 3:00 PM EST.
  • Evaluation Criteria: Lowest Price Technically Acceptable (LPTA), assessing Technical Requirements, Past Performance, and the lowest evaluated aggregate price. Offerors must provide pricing for all line items for base and option years.

Contact Information

For inquiries, contact Nancy Fernandez at nancy.fernandez@dla.mil or 445-737-0713.

People

Points of Contact

Jason C. WraySECONDARY

Files

Files

Download

Versions

Version 2Viewing
Pre-Solicitation
Posted: Apr 21, 2026
Version 1
Pre-Solicitation
Posted: Mar 12, 2026
View
Furosemide Tablets Solicitation | GovScope